| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 639977 | Null | 0.00165587325865807 | 0.30961289 |
| NSC 653147 | Null | 0.00165587325865807 | 0.44383234 |
| NSC 673181 | Null | 0.00165587325865807 | 0.12798197 |
| NSC 678343 | Null | 0.00165587325865807 | 0.26191057 |
| NSC 703544 | Null | 0.00165587325865807 | 0.33660952 |
| NSC 720299 | Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane | 0.00165587325865807 | 0.15847926 |
| NSC 722854 | 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline | 0.00165587325865807 | 0.14154813 |
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.00165587325865807 | 0.32821478 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.00165587325865807 | 0.38672075 |
| NSC 740024 | 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine | 0.00165587325865807 | 0.095646392 |